Three healthcare experts gave individual presentations on treatments for thyroid cancer, harmful substances that disrupt the body’s hormones, and rapid-reaction stroke treatment units at Weill Cornell Medicine-Qatar’s (WCM-Q) Grand Rounds
series.
WCM-Q graduate Dr Tania Jaber returned to Doha to give a presentation on radioactive iodine treatments for thyroid cancer, while Dr Thozhukat Sathyapalan, professor of endocrinology at the University of Hull, UK, explained that endocrine disruptors can cause a variety of conditions, including malignant tumours, birth defects and developmental
disorders, among others.
Dr Matthew Fink, Louis & Gertrude Feil Professor and department chair of neurology at Weill Cornell Medicine in New York, discussed how new mobile stroke treatment units are enabling earlier treatment of stroke victims and therefore dramatically improving long-term
outcomes.
Dr Fink, who is also associate dean of clinical affairs, said: “The focus is not just on survival, it’s on returning people to health and fully independent lives. With stroke, the faster treatment is given the higher the chances of full recovery. That is why these new mobile treatment units are so important.”
Mobile stroke treatment units are now operational in New York City and equipped with modern portable CT scanners to help mobile teams diagnose whether a stroke is ischemic or haemorrhagic in order to quickly administer the correct treatment and then transport the patient to the most appropriate facility.
Dr Sathyapalan explained that a wide range of substances are understood to disrupt the endocrine system, such as pesticides, certain types of plastic, heavy metals like lead and mercury, and bisphenol A, a chemical used in some types of plastic. Endocrine disruptors can adversely affect fertility and also pose a significant risk to unborn children and babies because their neural systems and organs are still growing and are highly sensitive to
hormonal changes.
Dr Jaber said research had found that thyroid cancer is the second most common cancer in the GCC region and between 1998 and 2002, Qatari females had the highest incidence of the disease of any group at 13.5 individuals per 100,000, versus Kuwait with seven.
Some thyroid cancers can be fairly successfully treated with radioactive iodine therapy.